HIGHLIGHTS
- What: The authors report a robust approach to evaluate MASH disease severity and improve clinical trial reliability using an AI-powered digital pathology tool-referred to as ‘AIM-MASH`-to quantify relevant histological tissue features. measurements enabled efficient slide-level quality assessments and exclusion of inadequate image areas. The authors demonstrate consistently accurate and reproducible AIM-MASH scoring.
- Who: Janani S. Iyer from the (UNIVERSITY) have published the article: AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases, in the Journal: (JOURNAL)
- Future: Future experiments should investigate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.